| 伊立替康在晚期食管癌治疗中的应用 |
| |
| 引用本文： | 毛丽丽,张晓东. 伊立替康在晚期食管癌治疗中的应用[J]. 肿瘤研究与临床, 2009, 22(10): 290-292. DOI: 10.3760/cma.j.issn.1006-9801.2010.05.002 |
| |
| 作者姓名： | 毛丽丽 张晓东 |
| |
| 作者单位： | 北京肿瘤医院,北京肿瘤防治研究所消化内科,北京大学临床肿瘤学院,100142; |
| |
| 摘 要： | 食管癌在中国具有较高的发病率和死亡率,伊立替康在胃肠道肿瘤包括食管癌的治疗中,显现出极具前景的抗肿瘤活性.文章对近年来伊立替康单药、以伊立替康为基础的联合化疗或放化疗在食管癌治疗中的进展进行了阐述.
|
| 关 键 词： | 食管肿瘤 伊立替康 顺铂 多西紫杉醇 放射疗法 计算机辅助 |
Application of Irinotecan in locally advanced or metastatic esophageal carcinoma |
| |
| MAO Li-li,ZHANG Xiao-dong. Application of Irinotecan in locally advanced or metastatic esophageal carcinoma[J]. Cancer Research and Clinic, 2009, 22(10): 290-292. DOI: 10.3760/cma.j.issn.1006-9801.2010.05.002 |
| |
| Authors: | MAO Li-li ZHANG Xiao-dong |
| |
| Abstract: | Esophageal carcinoma represents high incidence and mortality rate in China.Irinotecan (CPT-11) has shown promising activity in a number of gastrointestinal cancers,including esophageal cancer.This article reviews recent clinical trials of irinotecan-based chemotherapy and radiochemotherapy in esophageal carcinoma. |
| |
| Keywords: | Esophageal neoplasmsIrinotecanCisplatinDocetaxelRadiotherapy computerassisted |
|
